Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CONMED Corp
Report date March 01, 2023 · Filed March 03, 2023 · Amendment
Section 16 reporting ended · disclosed 2023-03-03. Current position is not established by this disclosure.
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 739 |
Last balance in matching sequence
After 2023-03-01 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2023-03-01 · Exercise / conversion · Acquired 250 · Balance 829 Row 2 · 2023-03-01 · Tax withholding · Disposed 90 · Balance 739 |
| Rsus (restricted Stock Units)SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2032-03-01 | Direct | 750 |
Reported balance
After 2023-03-01 transaction · row 3
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 3 · 2023-03-01 · Exercise / conversion · Disposed 250 · Balance 750 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2023 Filed Mar 3, 2023 14:55 UTC Amendment | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 250 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008541 · form4a.xml · derivative · entry 3 Peterson Jaclyn · CIK 0001871914 · VP of Mfg. & Adv. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750 Underlying: Common Stock · 250 shares Expires 2032-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 14:55 UTC Amendment | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 90 | $96.16 | $8,654.40 |
DisclosureSEC source: 0001127602-23-008541 · form4a.xml · nonDerivative · entry 2 Peterson Jaclyn · CIK 0001871914 · VP of Mfg. & Adv. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 739 Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 14:55 UTC Amendment | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-008541 · form4a.xml · nonDerivative · entry 1 Peterson Jaclyn · CIK 0001871914 · VP of Mfg. & Adv. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 829 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 10, 2022 Filed May 12, 2022 20:21 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionRsus (restricted Stock Units) · Derivative | 500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-014261 · form4.xml · derivative · entry 3 Peterson Jaclyn · CIK 0001871914 · VP of Mfg. & Adv. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500 Underlying: Common Stock · 500 shares Expires 2031-05-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| May 10, 2022 Filed May 12, 2022 20:21 UTC | CONMED Corp CNMD · Entity 4691 | Tax withholdingCommon Stock | 154 | $109.31 | $16,833.74 |
DisclosureSEC source: 0001127602-22-014261 · form4.xml · nonDerivative · entry 2 Peterson Jaclyn · CIK 0001871914 · VP of Mfg. & Adv. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 579 Read SEC document |
| May 10, 2022 Filed May 12, 2022 20:21 UTC | CONMED Corp CNMD · Entity 4691 | Exercise / conversionCommon Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-014261 · form4.xml · nonDerivative · entry 1 Peterson Jaclyn · CIK 0001871914 · VP of Mfg. & Adv. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 733 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 20:42 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 169 | $141.12 | $23,849.28 |
DisclosureSEC source: 0001127602-22-011219 · form4.xml · nonDerivative · entry 1 Peterson Jaclyn · CIK 0001871914 · VP of Mfg. & Adv. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233 Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:06 UTC | CONMED Corp CNMD · Entity 4691 | GrantOptions To Purchase Common Stock · Derivative | 16,000 | $0.00 Strike: $144.55 | $0.00 |
DisclosureSEC source: 0001127602-22-008096 · form4.xml · derivative · entry 2 Peterson Jaclyn · CIK 0001871914 · VP of Mfg. & Adv. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2032-03-01 F2 · derivative.exercise_date: The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:06 UTC | CONMED Corp CNMD · Entity 4691 | GrantRsus (restricted Stock Units) · Derivative | 1,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-008096 · form4.xml · derivative · entry 1 Peterson Jaclyn · CIK 0001871914 · VP of Mfg. & Adv. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2032-03-01 F1 · derivative.exercise_date: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts (25%) over a four year period. Read SEC document |
| December 31, 2021 Filed Jan 5, 2022 21:21 UTC | CONMED Corp CNMD · Entity 4691 | GrantCommon Stock | 64 | $134.67 | $8,618.88 |
DisclosureSEC source: 0001127602-22-000862 · form4.xml · nonDerivative · entry 1 Peterson Jaclyn · CIK 0001871914 · VP of Mfg. & Adv. Engineering 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.